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Background
Community and stakeholder engagement have increas-
ingly been acknowledged as best practice in the design
and implementation of global clinical research, results
dissemination and strategies for access to new health
products. Existing guidelines and best practices, how-
ever, provide little insight into the expected outcomes of
engagement activities, indicators of success, or useful
monitoring and evaluation (M&E) tools for assessing
impact on research and communities.
Methods
To fill this gap, a consortium of organizations (AVAC,
HANC, International HIV/AIDS Alliance, IAVI, NIAID,
TB Alliance and Wellcome Trust), developed and field
tested a user-friendly M&E Toolkit for engagement pro-
grams in clinical research settings in developing coun-
tries. From a broad review across clinical trial settings,
the toolkit builds on existing practices and introduces
new methods for M&E, indicators for impact and guide-
lines for effective use. The toolkit was piloted with TB
and/or HIV research sites in Africa and Asia that have a
history of incorporating engagement strategies in
research.
Results
New indicators for measuring the degree of engagement
and its impact on clinical research were identified. Parti-
cipants in pilot-testing utilized existing and new meth-
ods of evaluation, and assessed the relationship of these
strategies on targeted outcomes of clinical research.
Feedback and lessons learned are being incorporated
into a final version of the M&E Toolkit.
Conclusion
Understanding the impact of stakeholder engagement on
clinical research is critical for the development and
implementation of effective strategies, and for planning
and optimizing clinical trials and their outcomes in
developing countries. Through the use of the toolkit site
and sponsor staff can better evaluate strategies and
activities, demonstrate benefit, reallocate resources to
activities that were most productive, and make the case
for engaging stakeholders in research.
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